To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Similar Outcomes With Native Vitamin D and Eldecalcitol in Osteoporotic Women Taking Denosumab

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
November 2020

Similar Outcomes With Native Vitamin D and Eldecalcitol in Osteoporotic Women Taking Denosumab

Vol: 9| Issue: 11| Number:30| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparison of the Effects of Native Vitamin D and Eldecalcitol on Muscular Strength and Dynamic Balance in Patients with Postmenopausal Osteoporosis.

Prog Rehabil Med . 2020 Oct 30;5:20200026

Contributing Authors:
N Miyakoshi N Masutani Y Kasukawa D Kudo K Saito T Matsunaga Y Shimada

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Thirty postmenopausal women with osteoporosis receiving denosumab treatment were randomized to receive either native vitamin D plus calcium supplementation or active Vitamin D3 (eldecalcitol). The outcomes of interest included muscle strength, static and dynamic postural balance, sitting balance, serum biochemical analyses (e.g. 25 hydroxyvitamin D, calcium, phosphorous, creatinine, blood urea nit...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.